The design of the T900™ improves the capability of medical practitioners to deliver normothermic blood and fluids to the body. By warming fluids to optimal, precisely controlled temperatures, the T900™ protects patients against hypothermia.

Serious consequences associated with hypothermia include:

1. Increased risk of infection. Hypothermic patients have a surgical site infection (SSI) rate 46% higher than patients who are normothermic.

2. Reduced cardiac performance. Decreased contractility, impaired relaxation, and a profoundly negative inotropic effect occur more frequently in hypothermic patients.

3. Coagulopathies and increased blood loss. Bleeding time increases 100% for each 2ºC drop in body temperature.

4. Increased length of stay in both hospital and recovery room. Hypothermia reduces the body’s ability to metabolize many drugs and can have profound effects on neuromuscular blocking agents, anesthetics and cardiovascular drugs used during the perioperative period.

5. Increased mortality rate in hypothermic trauma victims as well as surgical patients. Hypothermic trauma patients have a greater incidence of mortality than do their normothermic counterparts with the same injury severity score.

6. Hypothermic patients report a longer recovery time from surgery than do their normothermic counterparts.

7. Hypothermia has a dulling effect on the central nervous system reducing both motor and cognitive function.